Skip to main content
OpenTrials

Clinical trial condition

Anatomic Stage III Breast Cancer AJCC v8

Explore clinical trials studying Anatomic Stage III Breast Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

122 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Anatomic Stage III Breast Cancer AJCC v8 trial results

Completed

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

NCT03218826

Conditions
Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Prostate Carcinoma, +42 more
Locations
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Melanoma, +85 more
Locations
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
  • Island Urology Honolulu, Hawaii, United States
View all 144 locations
View Trial Details
Completed

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

NCT04593277

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +38 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions